- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Dissociative Seizures in Sweden
Total 23 results
-
PfizerCompletedSeizure Disorder, PartialSpain, France, Italy, Australia, United Kingdom, Germany, Belgium, Netherlands, Austria, Sweden, Finland, South Africa, Switzerland
-
University College CorkUniversity College, London; Wellcome TrustCompletedNeonatal SeizuresUnited Kingdom, Ireland, Netherlands, Sweden
-
Great Ormond Street Hospital for Children NHS Foundation...Karolinska University Hospital; University College London Hospitals; Helsinki... and other collaboratorsCompletedNeonatal SeizuresUnited Kingdom, Sweden, Ireland, Netherlands
-
Eisai Inc.CompletedPartial Onset SeizuresGermany, Sweden, Norway, Austria, Denmark
-
University College CorkUniversity College, London; Wellcome TrustCompletedBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Epilepsy | Neurologic Manifestations | SeizuresUnited Kingdom, Ireland, Netherlands, Sweden
-
UCB PharmaCompletedEpilepsyFrance, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia
-
Eisai LimitedTerminatedEpilepsyUnited Kingdom, Germany, Hungary, Switzerland, Italy, Netherlands, Poland
-
Universitaire Ziekenhuizen KU LeuvenKing's College London; Karolinska Institutet; UCB Pharma; University of Coimbra; RWTH... and other collaboratorsCompletedEpilepsyBelgium, Germany, Portugal, Sweden, United Kingdom
-
Cyberonics, Inc.TerminatedEpilepsySweden, United Kingdom, Austria, Belgium, Germany
-
Eisai Inc.CompletedRefractory Partial SeizuresUnited States, France, Germany, Italy, United Kingdom, Belgium, Israel, South Africa, Finland, Russian Federation, Austria, Netherlands, Sweden, India
-
Karolinska InstitutetCompletedHypoxic Ischemic Encephalopathy | Neonatal Convulsions | Subgaleal HematomaSweden
-
Eisai Inc.CompletedPartial Onset SeizuresFrance, United Kingdom, Germany, Denmark, Czech Republic, Norway, Sweden, Ireland
-
Eisai Inc.CompletedEpilepsyGreece, Italy, Spain, Sweden, Korea, Republic of, Germany, Australia, France, Switzerland, Slovakia, Poland, Taiwan, Hungary, Serbia, India, United Kingdom, Denmark, Russian Federation, South Africa, Montenegro
-
UCB PharmaCompletedPartial EpilepsiesUnited States, Poland, United Kingdom, Switzerland, Hungary, Germany, Sweden, Lithuania
-
Eisai Inc.CompletedEpilepsyBelgium, France, United States, Czech Republic, Estonia, Latvia, Spain, United Kingdom, Lithuania, Germany, Australia, Finland, Netherlands, Sweden
-
UCB Biopharma SRLTerminatedDrug-Resistant Epilepsy | Focal-Onset SeizuresUnited States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerlan... and more
-
Starkey Laboratories, IncCompleted
-
Eisai Inc.CompletedEpilepsyBelgium, Germany, China, Hong Kong, United States, France, Romania, Mexico, South Africa, India, Portugal, Russian Federation, Italy, Canada, Australia, Taiwan, Austria, Malaysia, Hungary, Poland, Thailand, Sweden, Bulgaria, Serbia, Greece and more
-
UCB PharmaTerminatedEpilepsyUnited States, Belgium, Canada, Germany, Sweden, Czechia, Australia
-
UCB PharmaCompletedEpilepsyUnited States, Czechia, Germany, Poland, Austria, Belgium, Brazil, Bulgaria, Canada, Estonia, Finland, France, Hong Kong, Hungary, India, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Puerto Rico, Russian Federation and more
-
Sage TherapeuticsCompletedSuper-Refractory Status EpilepticusUnited States, Austria, Canada, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Serbia, Spain, Sweden, United Kingdom
-
SK Life Science, Inc.CompletedPartial EpilepsyUnited States, Spain, Korea, Republic of, Serbia, Germany, Bulgaria, Argentina, Australia, Chile, Czechia, Hungary, Mexico, Poland, Russian Federation, Sweden, Thailand, Ukraine
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom